However, a recent study by Shin et al. showed that a high pretreatment plasma sPD-L1 level was an independent prognostic factor in multivariate analysis for worse OS in advanced gastric cancer patients receiving first-line chemotherapy [46]. Here, SPDL1 is linked to gastric cancer.